COCH
Envoy Medical, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.71
−2.75%Year over year
Reported trailing growth
- Revenue
- -6.8%
- EBITDA
- -13.6%
- EBIT
- -20.1%
- EPS
- +49.8%
- Free cash flow
- -40.4%
- Operating cash flow
- -40.0%
Forward estimates
Based on analyst estimates
- Revenue
- -3.4%
- EBITDA
- -24.8%
- EPS
- +60.6%
Three-year CAGR
- Revenue
- +0.6%
- EBITDA
- -10.4%
- EBIT
- -15.7%
- Net income
- -14.2%
- EPS
- +17.4%
- Free cash flow
- +2.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026